Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10374 in moderate to severe plaque psoriasis
NCT06077331Phase 2Recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Sep 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10374 in plaque psoriasis, sponsored by Hansoh Pharmaceutical Group. Started Sep 2023; status: recruiting.
02
Drugs
HS-10374
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06077331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06077331.